ANSELL LIMITED (ANN)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

ANN

ANN - ANSELL LIMITED

FNArena Sector : Commercial Services & Supplies
Year End: June
GICS Industry Group : Health Care Equipment & Services
Debt/EBITDA: 1.78
Index: ASX100 | ASX200 | ASX300 | ALL-ORDS

Ansell is an Australian manufacturer of protective industrial equipment and household and medical gloves. It is the remnant of Pacific Dunlop, once a mighty conglomerate that listed in 1985. The name was changed to Ansell in 2002.

LAST PRICE CHANGE +/- CHANGE % VOLUME

$40.29

27 Aug
2026

0.690

OPEN

$39.23

1.74%

HIGH

$40.49

1,574,461

LOW

$39.12

TARGET
$36.625 -9.1% downside
OTHER COMPANIES IN THE SAME SECTOR
AIM . AL3 . ASB . CUP . DGL . IMB . KPG . RDX . SRV .
FNARENA'S MARKET CONSENSUS FORECASTS
ANN: 1
Title FY27
Forecast		 FY28
Forecast
EPS (cps) 250.3 xxx
DPS (cps) 118.2 xxx
EPS Growth N/A xxx
DPS Growth N/A xxx
PE Ratio 16.4 xxx
Dividend Yield 2.9% xxx
Div Pay Ratio(%) 47.2% xxx
This company reports in USD.
All estimates have been converted into AUD by FNArena at present FX values.

Dividend yield today if purchased 3 years ago: N/A

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

 N/A

Estimated Dividend Growth
(Average Of Past Three Years)

  %

Amount Invested

 $ 

Tell Me The Dividend After This Many Years
Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages

Last ex-div: 23/02 - (franking ex-div 37.54c)

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2026 FactSet UK Limited. All rights reserved
Title 202120222023202420252026
EPS Basic xxxxxxxxxxxxxxx215.6
DPS All xxxxxxxxxxxxxxx95.4
Sales/Revenue xxxxxxxxxxxxxxx3,158.4 M
Book Value Per Share xxxxxxxxxxxxxxx2,061.8
Net Operating Cash Flow xxxxxxxxxxxxxxx512.8 M
Net Profit Margin xxxxxxxxxxxxxxx9.75 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 202120222023202420252026
Return on Capital Employed xxxxxxxxxxxxxxx10.49 %
Return on Invested Capital xxxxxxxxxxxxxxx7.73 %
Return on Assets xxxxxxxxxxxxxxx6.18 %
Return on Equity xxxxxxxxxxxxxxx10.49 %
Return on Total Capital xxxxxxxxxxxxxxx11.99 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx324.2 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 202120222023202420252026
Short-Term Debt xxxxxxxxxxxxxxx104 M
Long Term Debt xxxxxxxxxxxxxxx988 M
Total Debt xxxxxxxxxxxxxxx1,092 M
Goodwill - Gross xxxxxxxxxxxxxxx2,127 M
Cash & Equivalents - Generic xxxxxxxxxxxxxxx360 M
Price To Book Value xxxxxxxxxxxxxxx1.54

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 202120222023202420252026
Capex xxxxxxxxxxxxxxx72.3 M
Capex % of Sales xxxxxxxxxxxxxxx2.29 %
Cost of Goods Sold xxxxxxxxxxxxxxx1,850 M
Selling, General & Admin. Exp & Other xxxxxxxxxxxxxxx813 M
Research & Development xxxxxxxxxxxxxxx32 M
Investments - Total xxxxxxxxxxxxxxx5 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

0.0

No. Of Recommendations

6
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

UBS

xx/xx/xxxx

3

xxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Morgan Stanley

xx/xx/xxxx

3

xxxxx-xxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Ord Minnett

xx/xx/xxxx

3

xxxxxxxxx xx xxxx xxxx xxxxxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Morgans

25/08/2026

3

Hold

$37.85

-6.06%

Ansell's FY26 result was strong, with adjusted earnings up 18% to the top end of guidance. Importantly for Morgans, second half adjusted sales growth accelerated to 9.2% with volumes improving, providing some evidence that a volume recovery is emerging.

While FY27 earnings guidance (6%-14%) looks solid, the majority of gains comes from FX and buybacks rather than operating earnings, with sustainability of Healthcare growth and Industrial margins yet to be proven.

While Ansell has done well in offsetting US tariffs and Middle East-related cost inflation through pricing, sourcing and supply-chain resilience, Morgans believes the market is increasingly pricing a sustained improvement in organic growth and cost savings which may be more difficult to obtain.

Hold retained, target rises to $37.85 from $35.23.

FORECAST
Morgans forecasts a full year FY27 dividend of 107.59 cents and EPS of 238.44 cents.
Morgans forecasts a full year FY28 dividend of 114.86 cents and EPS of 254.43 cents.

Macquarie

xx/xx/xxxx

3

xxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Citi

xx/xx/xxxx

3

xxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial
Access Stockbroker Research History >
EXTRA COVERAGE
Display All Commentary

No. Of Recommendations

0

Please note: unlike Broker Call Report, BC Extra is not updated daily. The info you see might not be the latest. FNArena does its best to update ASAP.

BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY
Access Extra Coverage Research History >

ANN STOCK CHART

FNArena News on ANN

1
FNArena Corporate Results Monitor – 25-08-2026

Aug 25 2026 - Australia
2
Treasure Chest: Beware Aussie Healthcare

Jul 17 2026 - Treasure Chest
3
Rudi’s View: AI To The Rescue

Jun 25 2026 - Rudi's View
4
Rudi’s View: When Aussie Companies Move Overseas

Jun 17 2026 - Rudi's View
5
April In Review: An Inflection Point

May 06 2026 - Australia

Latest Commercial Services & Supplies News

1
AI Infrastructure: From Capex To Productivity

Jul 30 2026 - Australia
2
Is DRAM At A Permanently Higher Plateau?

Jul 23 2026 - International
3
AI Dilemma: Value Creation Versus Value Capture

Jul 16 2026 - International
4
AI: It Is And Isn’t A Bubble

Jul 14 2026 - International
5
Silicon Shock: The Macro Of Tech Inflation

Jul 13 2026 - International
6
Treasure Chest: WiseTech Global

Jul 09 2026 - Treasure Chest
7
Codan Shares Ready To Rally

Jun 23 2026 - Technicals
8
Treasure Chest: Elsight & Electro Optic Systems

Jun 17 2026 - Treasure Chest
9
Rudi’s View: Market Momentum & Investor Dilemmas

Jun 10 2026 - Rudi's View
10
Rudi’s View: Tech Is Back (Ahead Of Tax Loss Selling)

Jun 03 2026 - Rudi's View